EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of HIV infected children with highly antiretroviral therapy consisting of indinavir, zidovudine and lamivudine 3-Year follow-up



Treatment of HIV infected children with highly antiretroviral therapy consisting of indinavir, zidovudine and lamivudine 3-Year follow-up



International Journal of Antimicrobial Agents 17(Supplement 1): S104, June




(PDF 0-2 workdays service: $29.90)

Accession: 035980455

Download citation: RISBibTeXText



Related references

Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine. Aids 17(16): 2345-2349, 2003

Treatment of HIV infected children with indinavir, zidovudine and lamivudine Two-year follow-up. AIDS (Hagerstown) 14(Supplement 4): S81, October, 2000

Dutch multicenter trial on the treatment of HIV infected children with indinavir, zidovudine and lamivudine 1 year follow-up. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 39: 522, 1999

Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial. JAMA 285(9): 1155-1163, 2001

AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients. Aids 14(4): 367-374, 2000

A two-year follow-up of zidovudine plus lamivudine combined with indinavir in antivival naive HIV-infected patients. Kansenshogaku Zasshi. Journal of the Japanese Association for Infectious Diseases 74(2): 128-133, 2000

A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: selection of thymidine analog regimen therapy (START II). Aids 14(11): 1601-1610, 2000

Evolution of antiretroviral phenotypic and genotypic drug resistance in antiretroviral-naive HIV-1-infected children treated with abacavir/lamivudine, zidovudine/lamivudine or abacavir/zidovudine, with or without nelfinavir (the PENTA 5 trial). Antiviral Therapy 7(4): 293-303, 2003

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. New England Journal of Medicine 337(11): 734-739, 1997

Dutch multicenter trial on the treatment of HIV infected children with zidovudine, indinavir and lamivudine. AIDS (London) 12(SUPPL 4): S92, 1998

A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combination with indinavir in antiretroviral naive individuals with HIV infection: selection of thymidine analog regimen therapy (START I). Aids 14(11): 1591-1600, 2000

Indinavir, zidovudine, lamivudine: 3-year follow-up. Annals of Internal Medicine 134(2): 165-165, 2001

Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team. New England Journal of Medicine 341(25): 1865-1873, 1999

Pilot study of zidovudine-lamivudine combination therapy in vertically HIV-infected antiretroviral-naive children. Aids 12(5): 489-494, 1998